Revenue: The sum of all revenue fields included for a company's operating activities.
Collegium Pharmaceutical, Inc. (COLL) had Revenue of $631.45M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$631.45M |
$69.19M |
|
$254.10M |
|
$377.34M |
|
$461.55M |
|
$169.90M |
|
$-71.33M |
|
$98.57M |
|
$98.57M |
|
$69.19M |
|
$69.19M |
|
$69.19M |
|
$69.19M |
|
$169.90M |
|
$337.03M |
|
32.27M |
|
40.42M |
|
$2.14 |
|
$1.86 |
|
| Balance Sheet Financials | |
$482.26M |
|
$14.33M |
|
$1.18B |
|
$1.66B |
|
$509.51M |
|
$787.90M |
|
$925.24M |
|
$1.43B |
|
$228.84M |
|
$-824.89M |
|
$228.84M |
|
31.44M |
|
| Cash Flow Statement Financials | |
$204.98M |
|
$-287.76M |
|
$-60.60M |
|
$239.99M |
|
$96.61M |
|
$-143.38M |
|
$32.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.95 |
|
-- |
|
-- |
|
0.77 |
|
3.73 |
|
59.76% |
|
26.91% |
|
26.91% |
|
53.37% |
|
15.61% |
|
10.96% |
|
$203.33M |
|
-- |
|
-- |
|
-- |
|
0.38 |
|
7.15 |
|
2.76 |
|
132.10 |
|
30.23% |
|
-8.39% |
|
4.16% |
|
6.80% |
|
$7.28 |
|
$5.03 |
|
$5.07 |
|